First Round of Abstract Submission : September 23, 2018 | Welcome Message

Theme : Novel Discoveries for Diagnosis and Prevention of Breast Cancer

Organizing Committee Members

ABOUT CONFERENCE

Amiable welcome from Science Access to participants, from all around the world to attend the “3rd World Congress on Breast Cancer and Women’s Health” during March 04-06, 2019, London, UK. The Breast Cancer 2019 gatherings intend to investigate the crown examines in the tremendous field of science and united sciences.

Breast cancer is a disease which occurs when cells in the breast tissue change or mutate and keep reproducing. These irregular (abnormal cells) usually cluster together to form a tumor. This cancerous or malignant tumor invades other parts of the breast or when they spread (or metastasize) to other areas of the body through the lymphatic system or bloodstream. Breast cancer is caused by a genetic transformation in the DNA of breast cancer cells. Most of the breast cancers are diagnosed in women over age 50, but it’s not clear why some women get breast cancer and others do not. Some breast cancer risks may be preventable. Of course, you cannot control every variable that may influence your risk.

Breast Cancer 2019 gives an immaculate stage to bring out such quality research works. These gatherings are stretched out by commenting key administrative ranges like Multi-disciplinary Breast Cancer, Biological of Breast Cancer. Giving a possibility, Science Access breast cancer Conferences have researchers, analysts, substance associations and all agents of pharmaceutical and science organization divisions can exhibit their apt discoveries and in the meantime get presented to a helpful cluster of research and most recent improvements. This talk about the issues and achievements in the field of Breast Cancer Science Access Conferences has taken the start to accumulate the world-class specialists both from scholastic and industry in a typical stage at its Breast Cancer meetings with the Theme: Novel Discoveries for Diagnosis and Prevention of Breast Cancer.

Market Analysis

Brest cancer is the type of cancer developed in breast tissueFormation of a lump in a breast, red patches on the skin is the some of the common symptoms of the breast cancer. Obesity, lack of physical exercise, overexposure to radiation and drinking alcohol are some of the risk factors for developing breast cancer. According to WHO, it is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide and this number is continuously increasing. Prevalence of breast cancer is more common in developed countries compared with developing countries. The major factor for the growth of the market is an increasing number of females suffering from breast cancer. As no absolute treatment is available there is a scope for developing the market across the world. While on another hand the high cost of the treatment, adverse effects associated with the therapy and long approval time for the drugs are responsible for restraining the growth of the market.

The worldwide breast cancer treatment market is relied upon to enroll a CAGR of 8.5% amid the conjecture time frame 2018-2023. The breast cancer market is expected to grow because the high incidence rate of breast cancer is becoming a concern, and several pharmaceutical companies are progressively investing in research on breast cancer.

As Per World Health Organization (WHO) statistics, about one-third of these cancer fatalities can be decreased through earlier detection and treatment. Early breast cancer treatment and detection have improved the five-year survival rate for women diagnosed with cancer to nearly 80%.

Diagnostic and drug technology markets include a variety of products approved for the breast cancer treatment, including hormonal therapies, combinations, targeted therapies and chemotherapeutic drugs. Many side effects, adverse reactions, and safety concerns have come up associated with newer, innovative drugs. Therefore, drugs with improved safety and efficacy are needed to treat breast cancer effectively. With the foreseen increment in the number of breast cancer cases, breast cancer tumor innovative work is alluring and requires attention from pharmaceutical firms."Medications for breast cancer malignancy include a dynamic and developing worldwide market."

The breast cancer drugs market is estimated to reach REDACTED billion by 2022, with Roche predicted to account for more than half of the market. Common detection techniques for breast cancer are diagnostic mammography and ultrasound followed by a biopsy.

Key players for Global Breast Cancer Market:

GlaxoSmithKline (UK), AstraZeneca (UK), Apthera Inc (UK), Pfizer (US), Novartis AG (Switzerland), BioNumerik Pharmaceuticals (US), Oncogenex (US), Oncothyreon Inc (US), Astellas (Japan), Bipar Sciences (US), Puma Biotechnology (US), Sanofi S.A. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche (Switzerland), , Genentech (US), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (US), Bristol-Myers Squibb company (US), Actavis, Inc. (the US), Hospira, Inc. (the US), Bayer AG (Germany).Breast cancer screening market in Europe will be less than US$ 8 Billion by the end of the year 2022.

Breast cancer is one of the most dangerous diseases in the Europe region. Its incidence rate in Europe was 92.9 women per 100,000 women and mortality rate was 23.1 per 100,000 women. Hence, most of the countries of Europe has implemented or in the process to adopt breast cancer screening in their national cancer screening programs. Mammography screening is most commonly used as a breast cancer screening method in Europe.

Societies

UK Oncology Nursing Society, UK; The Breast Cancer Society of Canada, Canada; American Cancer Society, USA; National Breast Cancer Foundation (NBCF) Australia; New Zealand Breast Cancer Foundation, New Zealand; European Society for Medical Oncology , EUSOMA - European Society of Breast Cancer Specialists, Italy; The Breast Cancer Research Foundation, USA; Japanese Breast Cancer Society, Japan; Irish Cancer Society, Ireland; Austrian Cancer Society, Austria, German Cancer Society, Germany; Swedish Cancer Society, Sweden; European Association for Cancer Research (EACR); European Oncology Nursing Society (EONS); European Society of Surgical Oncology (ESSO); International Society of Paediatric Oncology (SIOP); Belgium Foundation Against Cancer; Cancer Society of Estonia; Cancer Society of Finland; German Cancer Research Center; Italian Cancer Patients Association; Norwegian Cancer Society; Spanish Association Against Cancer; Cancer Society of New Zealand.

Target Audience

Breast Cancer Surgeons, pathologists

Breast Care Nurse

Radiation Oncologist

Radiation Therapist

Medical Oncologist

Reconstructive (plastic) Surgeon

Lymphoedema Therapist

Nurse Practitioners/Nurses

Healthcare Faculty

Medical Colleges

Business Entrepreneurs

Training Institutes

Data Management Companies

Radiologist

Healthcare Associations and Societies

Manufacturing Medical Devices Companies

Worldwide Medicine universities

Harvard University

University of Minnesota

Mayo Medical School

Pittsburgh School of Medicine

Yale University

University of Cambridge

The University of Oxford Stanford University

Yale University

Emory University

John Hopkins University

Kings College London

Feinberg School of Medicine

University of Wisconsin

UNC School of Medicine

Karolinska University

The University of Tokyo

National University of Singapore (NUS)

Kyoto University

University of Hong Kong (HKU)

Peking University

Seoul National University (SNU)

National Taiwan University (NTU)

Osaka University

 

breastcancer@sasummits.com

womenhealth@sasummits.com

 

big-event
big-event

Target Audience

  • Presidents & CEO’s
  • Students
  • Surgeons
  • Nurses
  • Radiologists
  • Breast Cancer Biologist and oncologists

Contact Us

Feel Free To Contact Us

Address   : 2737 Live Oak Street, Huntington Park, CA 90255, USA
Phone No : +1 - 267-646-2200 , +1-302-428-9993
Fax           : +1 - 267-646-2200
Email Id    : Breastcancer@sasummits.com


MAIL US AT

 

Authorization Policy: By registering for the conference you grant permission to SCIENCEACCESS to photograph, film or record and use your name, likeness, image, voice, and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or video recording by participants/others during the conference is prohibited without prior approval. Contact us for any queries. Privacy is Everyone's Concern!